Guangbo Kang

机构：Tianjin University of Technology, Tianjin University · ORCID：0000-0001-5353-9788

发表论文 54 篇 · 总被引 1211 次 · h-index 20

代表论文

Affinity maturation of antibody fragments: A review encompassing the development from random approaches to computational rational optimization (2023 · International Journal of Biological Macromolecules · 被引 48)
A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation (2024 · Gut Microbes · 被引 35)
Synthetic bacterial therapies for intestinal diseases based on quorum-sensing circuits (2023 · Biotechnology Advances · 被引 35)
A synthetic microbial consortium protects against obesity by regulating vitamin B6 metabolism (2024 · Gut Microbes · 被引 30)
Propionate‐producing engineered probiotics ameliorated murine ulcerative colitis by restoring anti‐inflammatory macrophage via the GPR43 / HDAC1 / IL ‐10 axis (2024 · Bioengineering & Translational Medicine · 被引 24)
Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities (2024 · Clinical and Translational Medicine · 被引 16)